{"id":"W4402584309","doi":"10.1186/s13223-024-00904-9","title":"fSCIG 10% in pediatric primary immunodeficiency diseases: a European post-authorization safety study","year":2024,"lang":"en","type":"article","venue":"Allergy Asthma and Clinical Immunology","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Takeda Pharmaceuticals International; Baxalta","keywords":"Medicine; Adverse effect; Tolerability; Pediatrics; Incidence (geometry); Primary immunodeficiency; Internal medicine; Disease","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001589519,0.000458957,0.0007404708,0.0004653475,0.0004134915,0.00009001225,0.0006293911,0.0004377729,0.0009554331],"category_scores_gemma":[0.0004393053,0.0004113512,0.0002889395,0.0007659341,0.000633386,0.0003303389,0.0005385675,0.001142787,0.001597302],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006990359,"about_ca_system_score_gemma":0.0002550701,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002227041,"about_ca_topic_score_gemma":0.00003624459,"domain_scores_codex":[0.9943965,0.001980591,0.001612832,0.001124958,0.00009183484,0.0007932808],"domain_scores_gemma":[0.9982807,0.0007522534,0.0001943178,0.0006267123,0.0001223384,0.00002367143],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.00541834,0.01564529,0.05020792,0.0002302315,0.003314351,0.0008098174,0.007931636,0.00008499183,0.01564392,0.01809442,0.0007899484,0.8818291],"study_design_scores_gemma":[0.003610492,0.002126098,0.9341533,0.00006182104,0.0001090522,0.0000757905,0.002638027,0.0000464543,0.000009493792,0.0001938976,0.05640899,0.0005665768],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8023058,0.1873372,0.0002044478,0.0004445725,0.002846764,0.0005284849,0.00003411143,0.0003117705,0.005986871],"genre_scores_gemma":[0.9876375,0.008528352,0.00000796407,0.0002311918,0.00003361558,0.00003403598,0.0004164969,0.00006059779,0.003050265],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8839454,"threshold_uncertainty_score":0.9999578,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008600951571196547,"score_gpt":0.2654386118535926,"score_spread":0.2568376602823961,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}